Enseval Putera Megatrading Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enseval Putera Megatrading Tbk PT with three other
drug stores in Asia:
Luyan Pharma Co Ltd
sales of 6.98 billion Chinese Renmimbi [US$1.01 billion]
of which 95%
was Pharmaceutical Wholesale),
Guangxi Liuzhou Pharmaceutical Co Ltd
(7.56 billion Chinese Renmimbi [US$1.10 billion]
of which 92%
was Wholesale), and
Cachet Pharmaceutical Company., Limited
based in China
(10.97 billion Chinese Renmimbi [US$1.59 billion]
of which 100%
Enseval Putera Megatrading Tbk PT reported sales of 18.93 trillion Indonesian Rupiahs (US$1.42 billion)
December of 2016.
increase of 8.4%
versus 2015, when the company's sales were 17.47 trillion Indonesian Rupiahs.
Sales at Enseval Putera Megatrading Tbk PT have increased during each of the previous five years
(and since 2011, sales have increased a total of 78%).
Sales of Other saw an increase
11.7% in 2016, from
2.47 trillion Indonesian Rupiahs to 2.76 trillion Indonesian Rupiahs.